Our lab studies blood vessel and lymphatic vessel development and maintenance. Proper assembly and upkeep of these vascular networks is critical for embryonic survival and adult health. We believe identifying genes that influence these processes will present new therapeutic options for the treatment of pathological vascular disorders.
In order to identify and study genes involved in vascular development and maintenance, we exploit ATP-dependent chromatin-remodeling complexes (CRCs). These complexes utilize energy derived from ATP hydrolysis to temporarily unravel and reorganize chromatin, thereby making DNA more accessible to proteins that positively or negatively modulate transcription. CRCs act selectively on the genome to regulate expression of specific target genes and can coordinate regulation of multiple genes to influence precise developmental programs. For these reasons, we believe CRCs present unique opportunities for identifying genes that mediate vascular development and maintenance and for elucidating their functions.
Each CRC contains a central ATPase catalytic subunit that is required for its assembly and function. In order to study the role of CRCs in vascular development, we genetically delete these catalytic subunits in vascular cells and look for resulting phenotypes in mutant mice. We then use candidate and unbiased approaches to backtrack and identify misregulated CRC target genes that contribute to the vascular phenotypes. Our Research page describes focus areas that have arisen in the lab using this novel approach to study vascular development and maintenance.
Finally, we are fortunate to work in a stimulating intellectual environment within the Cardiovascular Biology Research Program at OMRF. The Program is comprised of ten labs, which all investigate various aspects of blood and vascular biology, and our interactions with our colleagues in the Program enriches our research.